Abstract
A new character, the A marker, for polioviruses is described. In the presence of Al+++ (1 to 100 mM) attenuated, but not virulent, strains of type 1 and type 2 polioviruses are stabilized so that they resist thermal inactivation at 50°C. Differences between the attenuated and virulent type 3 strains studied were of the opposite character and less marked. By the use of optimal concentrations of Al+++ (12 mM for type 1 and 1 mM for type 2) attenuated strains can be separated from mixtures containing virulent type 1 or 2 strains. The A marker was found to be correlated with the d but not the rct/40 or T marker. The A marker has been used for following genetic changes of vaccine strains after their multiplication in man.
Full Text
The Full Text of this article is available as a PDF (576.0 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- HODES H. L., ZEPP H. D., AINBENDER E. A physical property as a virus marker. Difference in avidity of cellulose resin for virulent (Mahoney) and attenuated (LSc, 2ab) strain of type 1 poliovirus. Virology. 1960 May;11:306–308. doi: 10.1016/0042-6822(60)90073-8. [DOI] [PubMed] [Google Scholar]
- HOLLINSHEAD A. C. Differences in chromatographic behavior on cellulose columns of virulent Mahoney and attnuated LSc strains of poliovirus and similarities of base ratios of their nucleic acids. Med Exp Int J Exp Med. 1960;2:303–309. doi: 10.1159/000134889. [DOI] [PubMed] [Google Scholar]
- HSIUNG G. D., MELNICK J. L. Effect of sodium bicarbonate concentration on plaque formation of virulent and attenuated polioviruses. J Immunol. 1958 Apr;80(4):282–293. [PubMed] [Google Scholar]
- KANDA Y., MELNICK J. L. In vitro differentiation of virulent and attenuated polioviruses by their growth characteristics on MS cells. J Exp Med. 1959 Jan 1;109(1):9–24. doi: 10.1084/jem.109.1.9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- LWOFF A. Factors influencing the evolution of viral diseases at the cellular level and in the organism. Bacteriol Rev. 1959 Sep;23(3):109–124. doi: 10.1128/br.23.3.109-124.1959. [DOI] [PMC free article] [PubMed] [Google Scholar]
- MELNICK J. L. Problems associated with the use of live poliovirus vaccine. Am J Public Health Nations Health. 1960 Jul;50:1013–1031. doi: 10.2105/ajph.50.7.1013. [DOI] [PMC free article] [PubMed] [Google Scholar]
- SABIN A. B. Properties and behavior of orally administered attenuated poliovirus vaccine. J Am Med Assoc. 1957 Jul 13;164(11):1216–1223. doi: 10.1001/jama.1957.62980110008008. [DOI] [PubMed] [Google Scholar]
- VOGT M., DULBECCO R., WENNER H. A. Mutants of poliomyelitis viruses with reduced efficiency of plating in acid medium and reduced neuropathogenicity. Virology. 1957 Aug;4(1):141–155. doi: 10.1016/0042-6822(57)90050-8. [DOI] [PubMed] [Google Scholar]
- WALLIS C., MELNICK J. L. Stabilization of poliovirus by cations. Tex Rep Biol Med. 1961;19:683–700. [PubMed] [Google Scholar]
- WOODS W. A., ROBBINS F. C. The elution properties of type 1 polioviruses from A1(OH)3 gel. A possible genetic attribute. Proc Natl Acad Sci U S A. 1961 Sep 15;47:1501–1507. doi: 10.1073/pnas.47.9.1501. [DOI] [PMC free article] [PubMed] [Google Scholar]